Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
DURHAM, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), […]
Akoustis Secures a wBMS Design Win with Tier-1 Automotive Product Supplier
First BAW Design Win at a Tier-1 Automotive Customer in the Fast-Growing EV Market Segment Based on IC Reference Design […]
Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the Management of Fibromyalgia
Results from two positive Phase 3 studies point to Tonmya’s (TNX-102 SL) potential as a new first-line medicine for chronic […]
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the […]
GRIID to Begin Trading on Nasdaq Global Market Under Ticker “GRDI”
CINCINNATI, Jan. 29, 2024 (GLOBE NEWSWIRE) — GRIID Infrastructure Inc. (“GRIID” or the “Company”) (NASDAQ: GRDI) (NEO: GRDI), an American […]
Lantronix Wins Smart Buildings Innovation Award for POE++ Switch From IoT Evolution World
IRVINE, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for […]
Applied UV Inc. Announces Receipt of Provisional Patent for Our Pulse Modulated UVC LED System to be Added to Our Patented Fighter Flex LED Solution Expanding Significant Revenue Opportunity
DENVER, CO, Jan. 29, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Applied UV Inc. (NASDAQ: AUVI), a leader in smart […]
ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
BAUDETTE, Minn., Jan. 29, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that […]
Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market
KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary […]
Oculis to Present at Upcoming February Investor Conferences
ZUG, Switzerland and BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company […]
